Trials / Completed
CompletedNCT03320603
Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants
Administration of PCC in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants: Impact of an Expert ECRF on Adherence to Rules of Proper Use and Outcome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 397 (actual)
- Sponsor
- Octapharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is assessing the impact of an expert eCRF on the management of severe bleeding in the administration of Prothrombin Complex Concentrate in patients treated with oral anticoagulants and adherence to recommendations or experts' consensus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Expert eCRF | An expert eCRF will be used to guide physicians during the management of patients treated with Vitamin K Agonist or Direct Oral Anticoagulant admitted in emergency units for severe bleeding. |
| OTHER | Prothrombin Complex Concentrate | Prothrombin Complex Concentrate given as standard of care |
Timeline
- Start date
- 2017-10-13
- Primary completion
- 2020-12-20
- Completion
- 2020-12-20
- First posted
- 2017-10-25
- Last updated
- 2021-07-27
Locations
26 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03320603. Inclusion in this directory is not an endorsement.